William Jacob Savage sold $546k of IRON
Chief Medical Officer at Disc Medicine, Inc.. 9,158 shares at an average of $59.64, traded Nov 15, 2024, filed Nov 19, 2024.
Score components
- +15RoleOfficer
- +19Trade size$546k at market
- +5Share of holdings soldSold 18% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +5.7%, 3m -8.3%, 6m -15.9%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-24-128925, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 15, 2024 | MOption exercise Common Stock10b5-1 | +9,158 | $9.86 | $90k | 49,563 | Nov 19, 2024 |
| Nov 15, 2024 | SOpen-market sale Common Stock10b5-1 | -7,839 | $59.54 | $467k | 41,724 | Nov 19, 2024 |
| Nov 15, 2024 | SOpen-market sale Common Stock10b5-1 | -1,219 | $60.16 | $73k | 40,505 | Nov 19, 2024 |
| Nov 15, 2024 | SOpen-market sale Common Stock10b5-1 | -100 | $61.10 | $6,110 | 40,405 | Nov 19, 2024 |
| Nov 15, 2024 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -9,158 | $0.00 | $0 | 36,034 | Nov 19, 2024 |
Related signals
Other insiders at Disc Medicine, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 45Moderate | IRONsell Disc Medicine, Inc. | Kevin Bitterman director | $1.9M 27,136 shares | -100% | |
| 6Weak | Disc Medicine, Inc. | Kevin Bitterman director | $135k 1,689 shares | -1% | |
| 25Weak | Disc Medicine, Inc. | Kevin Bitterman director | $4.4M 54,496 shares | -16% | |
| 20Weak | Disc Medicine, Inc. | Jean M. Franchi Chief Financial Officer | $105k 2,000 shares | -3% | |
| 14Weak | Disc Medicine, Inc. | William Jacob Savage Chief Medical Officer | $150k 2,996 shares | -5% | |
| 15Weak | Disc Medicine, Inc. | William Jacob Savage Chief Medical Officer | $334k 6,677 shares | -10% | |
| 5Weak | Disc Medicine, Inc. | William Jacob Savage Chief Medical Officer | $105k 2,100 shares | -3% | |
| 37Weak | Disc Medicine, Inc. | Mona Ashiya director | $310k 5,738 shares | -1% | |
| 37Weak | Disc Medicine, Inc. | Orbimed Advisors LLC director | $310k 5,738 shares | -1% | |
| 53Moderate | Disc Medicine, Inc. | Mona Ashiya director | $2.8M 52,429 shares | -10% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.